Does difluoromethylornithine prevent recurrence in low-risk superficial bladder cancer?

被引：0
|
作者：
Herr, Harry W.
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Urol, New York, NY 10021 USA
[2] Cornell Univ, Coll Med, New York, NY USA
来源：
NATURE CLINICAL PRACTICE UROLOGY | 2007年 / 4卷 / 05期
关键词：
bladder neoplasms; eflornithine; polyamines; primary prevention;
D O I：
10.1038/ncpuro0753
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：240 / 241
页数：2
相关论文
共 50 条
  • [31] Comparison of Surveillance Strategies for Low-Risk Bladder Cancer Patients
    Zhang, Yuan
    Denton, Brian T.
    Nielsen, Matthew E.
    MEDICAL DECISION MAKING, 2013, 33 (02) : 198 - 214
  • [32] Mutation that may be linked to low-risk bladder cancer identified
    Spray, Nicole
    FUTURE ONCOLOGY, 2013, 9 (12) : 1801 - 1801
  • [33] Reduced recurrence of low-risk non-muscle-invasive bladder cancer is associated with low urine-specific gravity
    Iwasawa, Tomohiro
    Niwa, Naoya
    Matsumoto, Kazuhiro
    Komatsuda, Akari
    Ide, Hiroki
    Oya, Mototsugu
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (11) : 1019 - 1023
  • [34] EVALUATION OF AN ADJUVANT INSTILLATION TREATMENT MODALITY WITH A STANDARDIZED MISTLETOE EXTRACT TO PREVENT RECURRENCE OF SUPERFICIAL BLADDER CANCER
    Elsaesser-Beile, U.
    Leiber, Ch.
    Wetterauer, U.
    Mengs, U.
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3479 - 3479
  • [35] Interval to biochemical recurrence following radical prostatectomy does not affect survival in men with low-risk prostate cancer
    Bolton, D. M.
    Ta, A.
    Bagnato, M.
    Muller, D.
    Lawrentschuk, N. L.
    Severi, G.
    Syme, R. R.
    Giles, G. G.
    WORLD JOURNAL OF UROLOGY, 2014, 32 (02) : 431 - 435
  • [36] Interval to biochemical recurrence following radical prostatectomy does not affect survival in men with low-risk prostate cancer
    D. M. Bolton
    A. Ta
    M. Bagnato
    D. Muller
    N. L. Lawrentschuk
    G. Severi
    R. R. Syme
    G. G. Giles
    World Journal of Urology, 2014, 32 : 431 - 435
  • [37] Glutathione peroxidase I gene polymorphism and risk of recurrence in patients with superficial bladder cancer
    Zhao, H
    Liang, D
    Grossman, HB
    Wu, XF
    UROLOGY, 2005, 66 (04) : 769 - 774
  • [38] NMP22 IS PREDICTIVE OF RECURRENCE IN HIGH RISK SUPERFICIAL BLADDER CANCER PATIENTS
    Yau, Paul
    Chin, Joseph L.
    Pautler, Stephen
    Razvi, Hassan
    Izawa, Jonathan I.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 641 - 641
  • [39] Natural history, recurrence, and progression in superficial bladder cancer
    Sylvester, Richard J.
    THESCIENTIFICWORLDJOURNAL, 2006, 6 : 2617 - 2625
  • [40] LOW-RISK PROSTATE CANCER: DOES IT VANISH OR SIMPLY HIDE?
    Chu, Carissa
    Fasulo, Vittorio
    Washington, Samuel
    Cowan, Janet
    De la Calle, Claire
    Shoemaker, John
    Carroll, Peter
    JOURNAL OF UROLOGY, 2020, 203 : E344 - E345
12345